Skip to main content
. 2023 Jun 30;13(7):1012. doi: 10.3390/brainsci13071012

Table 3.

Average longevity of use in years of various medication classes in CRPS cases and matched controls.

Characteristic CRPS, N = 2510 1 Control, N = 2510 1 Difference 2 95% CI 2,3 p-Value 2 q-Value 4
Medication Class
Benzodiazepines 0.76 (1.83) 0.37 (1.30) 0.3876494024 0.30, 0.48 <0.001 <0.001
Bisphosphonates 0.11 (0.67) 0.07 (0.50) 0.0342629482 0.00, 0.07 0.041 0.047
Calcitonin 0.00 (0.04) 0.00 (0.03) 0.0007968127 0.00, 0.00 0.5 0.5
Capsaicin 0.08 (0.38) 0.03 (0.22) 0.0537848606 0.04, 0.07 <0.001 <0.001
Neuropathic pain medications 4.06 (5.18) 1.35 (3.17) 2.7147410359 2.5, 3.0 <0.001 <0.001
NSAIDs 3.11 (4.25) 2.21 (3.08) 0.9051792829 0.70, 1.1 <0.001 <0.001
Opioids 3.95 (5.21) 1.30 (2.57) 2.6442231076 2.4, 2.9 <0.001 <0.001
Steroids 1.07 (1.95) 0.66 (1.43) 0.4151394422 0.32, 0.51 <0.001 <0.001
None 0.00 (0.00) 0.00 (0.00) 0.0000000000

1 Mean (SD); 2 Welch Two Sample t-test; 3 CI = Confidence Interval; 4 False discovery rate correction for multiple testing.